Ramaswamy’s 2024 Proposal for Veterans’ Cannabis Access: Context and VA Guidance

During his 2024 presidential campaign, Vivek Ramaswamy proposed expanding veterans’ access to cannabis and certain psychedelics through the Department of Veterans Affairs. The remarks were campaign advocacy, rather than an announcement of a new VA treatment program. Ramaswamy ended that presidential campaign on January 15, 2024, after the Iowa caucuses.

What Ramaswamy Proposed in January 2024

According to Marijuana Moment’s January 15, 2024 report, Ramaswamy discussed the proposal during a virtual town hall ahead of the caucuses. He supported removing federal scheduling barriers for veterans with post-traumatic stress disorder (PTSD), with his veterans plan identifying marijuana, ayahuasca/DMT, and MDMA.

He framed access through the VA as an alternative to veterans turning to fentanyl or suicide. That was his political argument, not evidence that these substances prevent suicide or are interchangeable with established PTSD treatments.

The report also highlighted a tension in his explanation: he acknowledged a role for Congress but suggested that, as president, he could create a veterans-specific exception himself. A campaign statement should not be read as proof that a legal exception exists or that the proposed implementation was settled.

Policy Advocacy Is Separate From Treatment Evidence

The VA National Center for PTSD explains that the 2023 VA/DoD clinical practice guideline recommends against cannabis or cannabis derivatives as treatment for PTSD, citing insufficient evidence of effectiveness and associated risks. Support for researching a substance, changing its legal status, and recommending it for a specific patient are separate questions.

The VA’s clinician guide prioritizes trauma-focused psychotherapy and identifies sertraline, paroxetine, and venlafaxine as medication options supported by the guideline. Treatment should be selected with a clinician according to the person’s needs, preferences, and other health conditions. A political comparison with fentanyl does not describe the usual range of PTSD care.

What Veterans Should Know About Accessing Care

VA’s published guidance for veterans says marijuana use does not by itself result in denial of VA benefits, and participation in a state program does not remove eligibility for VA care. Veterans are encouraged to discuss their use with their care team so it can be considered in treatment planning.

That same guidance says VA clinicians may not recommend medical marijuana or complete state-program forms, VA pharmacies may not fill medical-marijuana prescriptions, and VA will not pay for them. Readers should consult VA directly about applicable policy rather than relying on this historical campaign proposal as an access pathway.

For veterans in emotional distress or concerned about their safety, the Veterans Crisis Line is available by calling 988 and pressing 1, or texting 838255. Help is available without waiting for a policy change.

Image credit